What’s in store for psychedelic therapy?

Psychedelic therapy is starting to gain mainstream acceptance in the medical world. With its promising research results in treating various behavioral health conditions, psychedelic substances stir widespread interest and attention. 2023 is likely to be a pivotal year for psychedelic-assisted treatment as it continues to march toward legalization in several states.

More and more companies begin to explore the potential benefits of this treatment; hence, further regulatory changes are expected to come to the forefront.

In this article, we’ll discuss psychedelic therapy, its positive effects, potential risks, and what the future holds.

Join our webcast: The Highs and Lows of Psychedelic Therapy: Navigating Legal Complexities

What is psychedelic therapy?

Also referred to as psychedelic-assisted psychotherapy or (PAP) is a psychotherapeutic practice where psychedelic drugs are used combined with talk therapy to treat mental health conditions.

Psychedelic substances can induce powerful psychological changes. Psilocybin, ketamine, and MDMA are increasingly used for treating various mental health issues like depression, anxiety, eating disorders, and post-traumatic stress disorder (PTSD). However, if misused, it can cause serious side effects to the patient, such as psychosis, fear, and cardiovascular problems.

What can psychedelics do?

While further research is still needed to confirm the therapeutic effects of psychedelic substances, here are some of their potential medical benefits according to studies:

• Relieve migraine and cluster headaches
• Reduce symptoms of anxiety and depression
• Increase emotional well-being
• Decrease OCD symptoms
• Treat substance use disorders (SUDs)

Potential risks and dangers

Here are the most common risks associated with the use of psychedelics:

• Psychosis – This psychological symptom is characterized by the loss of ability to recognize real events from imagination. It has been linked to the use of psychedelics and stimulants.
• Hallucinogen Persisting Perception Disorder (HPPD) – This causes patients to experience perceptual distortions for days to years after a person has taken psychedelics.
• Cardiovascular issues – A psychedelic user might suffer conditions, like hypertension and increased heart rate.

Additionally, when used chronically, an individual may experience anxiety, hallucination, and paranoia.

What the future holds

Psychedelic research and legalization efforts are coming into play. Investing opportunities are out there. With a glimpse of hope on the horizon, different businesses and providers are exploring the potential investments surrounding psychedelic treatment.

Companies are also starting to move in the digital space as more technological advancements are likely to come into the spotlight.

Research on psychedelic therapy signals a significant potential for this treatment in the coming years. As regulations continue to loosen, 2023 could be a banner period for psychedelics.

Save your seat in our webcast –The Highs and Lows of Psychedelic Therapy: Navigating Legal Complexities